Filana Therapeutics, Inc. (FLNA) Stock Ticker
FLNA right now
Market factors today
Unlock the full FLNA picture
About Filana Therapeutics, Inc.
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
FLNA stock facts
| Ticker symbol | FLNA |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $36.1M |
| CEO | Richard Jon Barry |
| Employees | 19 |
| Headquarters | Austin, TX, US |
| IPO date | 2000-07-14 |
| Website | www.filanatx.com |
What you can see for FLNA on Tickr
Live FLNA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the FLNA report.
Rankings
FAQ
What is the ticker symbol for Filana Therapeutics, Inc.?
The ticker symbol for Filana Therapeutics, Inc. is FLNA, listed on the NASDAQ Global Market.
What is FLNA?
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.